Aura Biosciences Inc

AURANASDAQ · USD
6.59USD0.00 (-2.08%)
317

Aura Biosciences Inc (AURA) Covered Calls

No qualifying covered call setups were found for AURA in the prior session.

Read more

Running AURA covered calls helps you generate consistent income from Aura Biosciences Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Aura Biosciences Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best AURA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if AURA stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling AURA covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Aura Biosciences Inc covered call is worth writing.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Income-focused investors, long-term AURA holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling AURA covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Aura Biosciences Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile68.25% Elevated
  • Market cap (M$)683
  • 52 weeks high-30.92%
  • 52 weeks low39.32%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$16.60
    151.90% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-12
  • P/E
  • Future P/E
  • EPS (ttm)-1.78
  • EPS growth next 5 years12.07%

As of September 17, 2026

No illustrative rows to display.

As of September 17, 2026

Sell covered calls with the data behind you

Find the best AURA covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial